{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:47Z","timestamp":1786119167660,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/yct.0b013e31817b06e0","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:12:40Z","timestamp":1242897160000},"page":"72-73","source":"Crossref","is-referenced-by-count":8,"title":["Electroconvulsive Therapy in Neuroacanthocytosis or McLeod Syndrome"],"prefix":"10.1097","volume":"25","author":[{"given":"Ma Jos\u00e9 Mart\u00edn","family":"V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carral","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"8","key":"R1-20-20210126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00109-002-0349-z","article-title":"Clinical features and molecular bases of neuroacanthocytosis.","volume":"80","author":"Rampoldi","year":"2002","journal-title":"J Mol Med"},{"issue":"5","key":"R2-20-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2006-948329","article-title":"Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram.","volume":"39","author":"Habermeyer","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"R3-20-20210126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2007-970141","article-title":"Authors' reply: obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.","volume":"40","author":"Habermeyer","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"R5-20-20210126","first-page":"108","article-title":"ECT for the treatment of Huntington's disease: a case study.","volume":"13","author":"Beale","year":"1997","journal-title":"Convuls Ther"},{"issue":"2","key":"R6-20-20210126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1176\/jnp.6.2.154","article-title":"ECT as a treatment for depression in Huntington's disease.","volume":"6","author":"Ranen","year":"1994","journal-title":"J Neuropsychol Clin Neurosci"},{"issue":"8","key":"R7-20-20210126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.12968\/ijpn.2006.12.8.368","article-title":"Palliative care and support for people with neurodegenerative conditions and theirs carers.","volume":"12","author":"Kristjanson","year":"2006","journal-title":"Int J Palliat Nurs"}],"container-title":["The Journal of ECT"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124509-200903000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:06Z","timestamp":1786038846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124509-200903000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/yct.0b013e31817b06e0","relation":{},"ISSN":["1095-0680"],"issn-type":[{"value":"1095-0680","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}